Patents Assigned to Ocugenics, LLC
  • Patent number: 8361492
    Abstract: Electrospun fibers are utilized to improve the mechanical characteristics of a contact lens reducing the weight and mechanical strength of the polymers from which the lenses are typically formed. Electrospun fibers are also utilized as a drug delivery system, both through direct use in the eye and by inclusion of the fibers in a contact lens. The fibers are loaded with therapeutic drugs by a variety of methods and processed by coating and cross-linking the fibers.
    Type: Grant
    Filed: June 24, 2009
    Date of Patent: January 29, 2013
    Assignee: Ocugenics, LLC
    Inventors: Shachar Tauber, Randall Fuerst, Keela Davis, Lyle Bowman, Gary Wnek, Joseph J. Bango, Jr.
  • Patent number: 8083347
    Abstract: Electrospun fibers are utilized to improve the mechanical characteristics of a contact lens reducing the weight and mechanical strength of the polymers from which the lenses are typically formed. Electrospun fibers are also utilized as a drug delivery system, both through direct use in the eye and by inclusion of the fibers in a contact lens. The fibers are loaded with therapeutic drugs by a variety of methods and processed by coating and cross-linking the fibers.
    Type: Grant
    Filed: April 1, 2009
    Date of Patent: December 27, 2011
    Assignee: Ocugenics, LLC
    Inventors: Joseph J. Bango, Jr., Lyle Bowman, Gary Wnek, Shachar Tauber, Randall Fuerst
  • Patent number: 7579442
    Abstract: A method and means of providing stromal repair and improved refractive correction by creating corneal stromal collagen tissue with fibril diameter and spacing that duplicates the optical transmission and diffusion characteristics of natural corneal collagen. The repair method includes implanting the collagen scaffold during laser corneal ablation or other interlamellar surgery to improve visual acuity or to preclude the possibility of ectasia.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: August 25, 2009
    Assignee: Ocugenics, LLC
    Inventors: Joseph J. Bango, John B. Fenn
  • Patent number: 7563396
    Abstract: A method and means of providing an improved refractive correction contact lens which increases user comfort, retards protein and lipid deposition, and can be utilized for pharmaceutical delivery. The invention discloses a technique for creating polymer fibril diameters and spacing that duplicates the optical transmission and diffusion characteristics of natural corneal collagen.
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: July 21, 2009
    Assignee: Ocugenics, LLC
    Inventors: Randall Fuerst, Joseph Bango, John Fenn, Michael Dziekan